nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Photosensitivity reaction—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Gatifloxacin—Anorexia—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Decreased appetite—Cisplatin—testicular cancer	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—testicular cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Vomiting—Bleomycin—testicular cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Hypotension—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Rash—Bleomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Dermatitis—Bleomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Hypersensitivity—Ifosfamide—testicular cancer	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Asthenia—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Feeling abnormal—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Pruritus—Ifosfamide—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Nausea—Bleomycin—testicular cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—testicular cancer	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Diarrhoea—Ifosfamide—testicular cancer	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Body temperature increased—Cisplatin—testicular cancer	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—testicular cancer	0.00111	0.00111	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Dizziness—Ifosfamide—testicular cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Vomiting—Ifosfamide—testicular cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Hypersensitivity—Cisplatin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Rash—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Dermatitis—Ifosfamide—testicular cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Asthenia—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—testicular cancer	0.000986	0.000986	CcSEcCtD
Gatifloxacin—Nausea—Ifosfamide—testicular cancer	0.00098	0.00098	CcSEcCtD
Gatifloxacin—Diarrhoea—Cisplatin—testicular cancer	0.000973	0.000973	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—testicular cancer	0.000972	0.000972	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—testicular cancer	0.000968	0.000968	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—testicular cancer	0.000961	0.000961	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—testicular cancer	0.00096	0.00096	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—testicular cancer	0.000956	0.000956	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—testicular cancer	0.000951	0.000951	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—testicular cancer	0.000937	0.000937	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—testicular cancer	0.000937	0.000937	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—testicular cancer	0.000935	0.000935	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—testicular cancer	0.000925	0.000925	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—testicular cancer	0.000923	0.000923	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—testicular cancer	0.000922	0.000922	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—testicular cancer	0.000917	0.000917	CcSEcCtD
Gatifloxacin—Vomiting—Cisplatin—testicular cancer	0.000904	0.000904	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—testicular cancer	0.000901	0.000901	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—testicular cancer	0.000899	0.000899	CcSEcCtD
Gatifloxacin—Rash—Cisplatin—testicular cancer	0.000897	0.000897	CcSEcCtD
Gatifloxacin—Dermatitis—Cisplatin—testicular cancer	0.000896	0.000896	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—testicular cancer	0.000895	0.000895	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—testicular cancer	0.000892	0.000892	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—testicular cancer	0.000889	0.000889	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—testicular cancer	0.000887	0.000887	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—testicular cancer	0.000866	0.000866	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—testicular cancer	0.000862	0.000862	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—testicular cancer	0.000859	0.000859	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—testicular cancer	0.000854	0.000854	CcSEcCtD
Gatifloxacin—Nausea—Cisplatin—testicular cancer	0.000845	0.000845	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—testicular cancer	0.000829	0.000829	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—testicular cancer	0.000829	0.000829	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—testicular cancer	0.000822	0.000822	CcSEcCtD
Gatifloxacin—Rash—Etoposide—testicular cancer	0.000822	0.000822	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—testicular cancer	0.000821	0.000821	CcSEcCtD
Gatifloxacin—Headache—Etoposide—testicular cancer	0.000816	0.000816	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—testicular cancer	0.000814	0.000814	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—testicular cancer	0.000814	0.000814	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—testicular cancer	0.000814	0.000814	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—testicular cancer	0.000813	0.000813	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—testicular cancer	0.000811	0.000811	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—testicular cancer	0.000801	0.000801	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—testicular cancer	0.000796	0.000796	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—testicular cancer	0.000787	0.000787	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—testicular cancer	0.000787	0.000787	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—testicular cancer	0.000781	0.000781	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—testicular cancer	0.000775	0.000775	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—testicular cancer	0.000775	0.000775	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—testicular cancer	0.000774	0.000774	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—testicular cancer	0.000764	0.000764	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—testicular cancer	0.000755	0.000755	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—testicular cancer	0.000744	0.000744	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—testicular cancer	0.000744	0.000744	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—testicular cancer	0.000737	0.000737	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—testicular cancer	0.00073	0.00073	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—testicular cancer	0.000729	0.000729	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—testicular cancer	0.000728	0.000728	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—testicular cancer	0.000726	0.000726	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—testicular cancer	0.000718	0.000718	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000711	0.000711	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—testicular cancer	0.000706	0.000706	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—testicular cancer	0.000706	0.000706	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—testicular cancer	0.000701	0.000701	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—testicular cancer	0.000696	0.000696	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—testicular cancer	0.000694	0.000694	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—testicular cancer	0.000687	0.000687	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—testicular cancer	0.000681	0.000681	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—testicular cancer	0.000679	0.000679	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—testicular cancer	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—testicular cancer	0.000656	0.000656	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000653	0.000653	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—testicular cancer	0.000649	0.000649	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—testicular cancer	0.000643	0.000643	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—testicular cancer	0.000643	0.000643	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—testicular cancer	0.000632	0.000632	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—testicular cancer	0.00062	0.00062	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—testicular cancer	0.000617	0.000617	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—testicular cancer	0.000617	0.000617	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—testicular cancer	0.000607	0.000607	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—testicular cancer	0.000588	0.000588	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—testicular cancer	0.000577	0.000577	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—testicular cancer	0.000577	0.000577	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—testicular cancer	0.000575	0.000575	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—testicular cancer	0.00056	0.00056	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—testicular cancer	0.000552	0.000552	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—testicular cancer	0.000537	0.000537	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—testicular cancer	0.000534	0.000534	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—testicular cancer	0.000524	0.000524	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—testicular cancer	0.000517	0.000517	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—testicular cancer	0.000516	0.000516	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—testicular cancer	0.0005	0.0005	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—testicular cancer	0.000496	0.000496	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—testicular cancer	0.000492	0.000492	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—testicular cancer	0.000492	0.000492	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—testicular cancer	0.000489	0.000489	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—testicular cancer	0.000464	0.000464	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—testicular cancer	0.00046	0.00046	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—testicular cancer	0.000434	0.000434	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—testicular cancer	0.000426	0.000426	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—testicular cancer	0.000423	0.000423	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—testicular cancer	0.000401	0.000401	CcSEcCtD
